Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | CVS | GILD |
|---|
| Close | 91.72 | 147.68 |
| Market Cap | $117B | $183B |
| 1M | −2.44% | +6.31% |
| P/E (TTM) | 24.4 | — |
| Forward P/E | 13.2 | 25.3 |
| P/E 5-Yr Percentile | 65 | — |
| P/S | 0.3 | 6.0 |
| P/B | 1.5 | 15.3 |
| Dividend Yield | 3.49% | 3.98% |
| Latest Quarter Revenue | $106B | $7.8B |
| Revenue YoY | +7.3% | +10.2% |
| Gross Margin | 44.5% | 79.8% |
| Latest Quarter EPS | 2.31 | -8.45 |
| Avg Post-Earnings Move | ±2.3% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 3.01% |
| 90-Day Net Insider Buying | — | −$15.4M |
CVS · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
